Form 13-F position report

POSEIDA THERAPEUTICS INC

Reported by Ikarian Capital LLC

PSTX CUSIP 73730P108 Manager CIK 0001778253

Reported 0 shares, down 85,837 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 5 Through Q3 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for POSEIDA THERAPEUTICS INC held by Ikarian Capital LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2021 Reduced 0 -85,837 (-100.0%) 0 $0 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

75 managers reported POSEIDA THERAPEUTICS INC for Q3 2021.

Managers reporting POSEIDA THERAPEUTICS INC in Q3 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 9,350,789 +27,583 < 0.01% $68,167,000 5 qtrs
Pentwater Capital Management LP Unchanged 4,967,227 0 0.37% $36,211,000 5 qtrs
BlackRock Inc Reduced 2,533,139 -8,686 < 0.01% $18,466,000 5 qtrs
VANGUARD GROUP INC Added 1,515,194 +184,743 < 0.01% $11,046,000 5 qtrs
Aisling Capital Management LP Unchanged 1,043,267 0 1.52% $7,605,000 5 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 909,856 -136,267 < 0.01% $6,633,000 5 qtrs
PERCEPTIVE ADVISORS LLC Unchanged 787,745 0 0.08% $5,743,000 5 qtrs
ADAGE CAPITAL PARTNERS GP L L C Reduced 755,969 -518,944 0.01% $5,511,000 5 qtrs
STATE STREET CORPORATION Added 521,513 +7,521 < 0.01% $3,802,000 5 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 376,749 +205 < 0.01% $2,746,000 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2021
Filed
November 15, 2021
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.